10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2020 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 18, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Operating activities | |||
| Net income | $ 4,572 | 4,807 | 3,750 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized (gains) losses on financial instruments | (182) | (67) | 206 |
| Depreciation and amortization | 1,154 | 1,133 | 1,132 |
| Deferred income taxes | (540) | 81 | 91 |
| Impairment of property and equipment | 198 | 0 | 0 |
| Share-based compensation | 283 | 294 | 226 |
| Changes in operating assets and liabilities: | |||
| Receivables, net | (256) | (1,053) | (695) |
| Other invested assets | (32) | (48) | (1) |
| Other assets | (283) | (170) | (26) |
| Policy liabilities | 3,528 | 1,826 | (1,059) |
| Unearned income | 202 | 115 | (36) |
| Accounts payable and other liabilities | 1,978 | (445) | 97 |
| Income taxes | 72 | (325) | 323 |
| Other, net | (6) | (87) | (181) |
| Net cash provided by operating activities | 10,688 | 6,061 | 3,827 |
| Investing activities | |||
| Purchases of investments | (19,492) | (22,954) | (9,671) |
| Proceeds from sale of investments | 11,318 | 18,598 | 9,662 |
| Maturities, calls and redemptions from investments | 4,741 | 2,437 | 1,938 |
| Changes in securities lending collateral | (849) | 254 | (149) |
| Purchases of subsidiaries, net of cash acquired | (1,976) | 0 | (1,760) |
| Purchases of property and equipment | (1,021) | (1,077) | (1,208) |
| Other, net | (45) | (50) | (71) |
| Net cash used in investing activities | (7,324) | (2,792) | (1,259) |
| Financing activities | |||
| Net repayments of commercial paper borrowings | (150) | (297) | (107) |
| Proceeds from long-term borrowings | 2,484 | 2,473 | 835 |
| Repayments of long-term borrowings | (1,932) | (1,123) | (1,684) |
| Proceeds from short-term borrowings | 970 | 7,590 | 9,120 |
| Repayments of short-term borrowings | (1,670) | (8,035) | (9,250) |
| Changes in securities lending payable | 849 | (254) | 150 |
| Proceeds from issuance of common stock under Equity Units stock purchase agreements | 0 | 0 | 1,250 |
| Repurchase and retirement of common stock | (2,700) | (1,701) | (1,685) |
| Cash dividends | (954) | (818) | (776) |
| Proceeds from issuance of common stock under employee stock plans | 176 | 187 | 173 |
| Taxes paid through withholding of common stock under employee stock plans | (128) | (84) | (81) |
| Other, net | 488 | (204) | (186) |
| Net cash used in financing activities | (2,567) | (2,266) | (2,241) |
| Effect of foreign exchange rates on cash and cash equivalents | 7 | 0 | (2) |
| Change in cash and cash equivalents | 804 | 1,003 | 325 |
| Cash and cash equivalents at beginning of year | 4,937 | 3,934 | |
| Cash and cash equivalents at end of year | 5,741 | 4,937 | 3,934 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |